ARWR: Arrowhead Pharmaceuticals Inc

15.70 USD 0.56 (3.44%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

ARWR exchange rate has changed by -3.44% for today. During the day, the instrument was traded at a low of 15.51 and at a high of 16.54.

Follow Arrowhead Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

ARWR News

Investing 13:40 Sarepta stock jumps as FDA may lift ELEVIDYS pause after safety review
Investing 11:38 Sarepta Therapeutics stock price target raised to $5 from $0 at H.C. Wainwright
Benzinga 09:41 Sarepta Therapeutics Surges Over 40% In Tuesday Pre-Market: What's Going On? - Arrowhead Pharma (NASDAQ:ARWR), Sarepta Therapeutics (NASDAQ:SRPT)
Investing 08:54 Bernstein initiates Sarepta Therapeutics stock with Market Perform rating
Investing 08:08 Sarepta Therapeutics stock rating upgraded by JPMorgan on FDA decision
Benzinga 12:48 FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys - Sarepta Therapeutics (NASDAQ:SRPT)
Investing 11:55 H.C. Wainwright reiterates Sell rating on Sarepta Therapeutics stock with $0 target
Investing 07:38 Barclays downgrades Sarepta stock to Underweight on Elevidys concerns
Benzinga 15:09 Sarepta Gets Thumbs Down From Regulators Regarding Gene Therapy - Sarepta Therapeutics (NASDAQ:SRPT)
Investor's Business Daily 14:04 Sarepta Therapeutics' Brutal Week Continues With Bad News Out Of Europe
Investing 18:01 Eli Lilly, GE Vernova Surge Among Wednesday’s Market Cap Stock Movers
Benzinga 15:00 GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday - Arrowhead Pharma (NASDAQ:ARWR), Abivax (NASDAQ:ABVX)
Seeking Alpha 17:30 How Negative Developments At Sarepta Impact Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Investor's Business Daily 12:58 Sarepta Makes A 'Painful' Decision. Will It Help Rebuild Investors' Confidence?
Benzinga 12:56 Sarepta Pauses Elevidys Shipments Amid FDA Safety Review - Sarepta Therapeutics (NASDAQ:SRPT)
Investing 18:01 Google, Linde lead market cap stock movers on Monday
Investing 18:01 Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers
Zacks 14:58 SRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline Pivots
Investing 15:17 CRISPR Therapeutics stock maintains outperform rating at William Blair
Investing 11:44 Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
Investing 21:20 Factbox-Fat, not muscle: Drugmakers in race for next weight-loss breakthrough
Reuters 14:41 Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Investing 19:07 Arrowhead Pharmaceuticals at Goldman Sachs Conference: Strategic Launch Plans
Investing 15:31 Arrowhead at Jefferies Conference: Strategic Pipeline Insights

Daily Range

15.51 16.54

Year Range

9.57 28.72

Previous Close: 15.92
Open: 16.26

Bid: 15.70
Ask: 16.00

Low: 15.51
High: 16.54

Volume: 3.667 K

Daily Change: -3.44%
Month Change: 0.26%

6 Months Change: -18.06%
Year Change: -44.82%

30 July, Wednesday